Observational studyThe journal of headache and pain2025

Tolerability of switch from erenumab to fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, real-world, observational study.

Faisal Mohammad Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.